Dela
The Americans with Disabilities Act ensures that people living with disabilities receive reasonable accommodations at work. That law also applies to students attending most colleges and universities. And the ADA doesn't limit itself to physical disabilities. It's often applied to invisible disabilities, as well.
This week, Britt Neff, the Access Specialist at the University of Washington School of Law, joins me to explain all the ways the accommodation process can work for college students living with MS.
We'll also tell you about PTD802, an oral remyelination therapy that's just been given a green light from the FDA to begin human clinical trials
We're sharing evidence from an important study that should make you feel more confident about getting those MMR (measles, mumps, rubella) and chickenpox vaccines.
You'll learn what researchers at the Cleveland Clinic discovered when they asked the question, "Can someone living with MS over the age of 60 discontinue their disease-modifying therapy?"
And we're sharing the details about an AI application that can predict -- with 90% accuracy -- whether someone with MS is at risk of experiencing cognitive decline over the next few years.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Understanding "reasonable accommodation" at college :22
FDA approves oral remyelination therapy PTD802 for Phase 1 clinical trial 1:07
Study results: MMR (measles, mumps, rubella) and chickenpox vaccines are shown to be safe for people with MS 4:52
Study results: Is it safe for someone living with MS over 60 to discontinue their DMT? 7:34
Study results: AI predicts future cognitive changes among people with MS with 90% accuracy 10:45
Britt Neff explains the many types of accommodation available to college students with MS 15:01
Share this episode 28:24
Next week 28:44
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/462
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com
Pheno Therapeutics
https://phenotherapeutics.com
STUDY: Live Attenuated MMR and Varicella Vaccinations and Multiple Sclerosis Activity
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2849165
STUDY: Long-Term Follow-Up of Patients with Multiple Sclerosis Over Age 60: Comparing Clinical and Radiological Outcomes in Disease-Modifying Therapy Continuers and Discontinuers
https://journals.sagepub.com/doi/full/10.1177/20552173261448005
STUDY: Explainable Artificial Intelligence to Predict Neurocognitive Disorder Progression in Multiple Sclerosis Using MRI and Clinical Data
https://onlinelibrary.wiley.com/doi/10.1111/ene.70568
JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms
REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review
Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 462
Guest: Britt Neff
Podden och tillhörande omslagsbild på den här sidan tillhör
Jon Strum. Innehållet i podden är skapat av Jon Strum och inte av,
eller tillsammans med, Poddtoppen.
Avsnitt sparat!
Du hittar sparade avsnitt på Mina sidor.
Kunde inte spara avsnitt
Något gick fel. Försök igen.